Literature DB >> 22487481

Role of radiation-induced granulocyte colony-stimulating factor in recovery from whole body gamma-irradiation.

Vijay K Singh1, Oluseyi O Fatanmi, Pankaj K Singh, Mark H Whitnall.   

Abstract

The purpose of this study was to further elucidate the radioprotective role of granulocyte colony-stimulating factor (G-CSF) induced in response to irradiation. The induction of G-CSF and interleukin-6 (IL-6) in response to radiation exposure was evaluated in mice. The level of cytokine in serum was determined by multiplex Luminex. The role of G-CSF on survival and tissue injury after total body gamma-irradiation was evaluated by administration of neutralizing antibody to G-CSF before radiation exposure. An isotype control was used for comparison and survival was monitored for 30 d after irradiation. Jejunum samples were used for immunohistochemistry. Ionizing radiation exposure induced significant levels of the hematopoietic cytokines G-CSF and IL-6, in mice receiving 9.2 Gy radiation. Maximal levels of G-CSF were observed in peripheral blood of mice 8h after irradiation. IL-6 levels were maximum at 12h after irradiation. Administration of G-CSF antibody significantly enhanced mortality in irradiated mice. G-CSF antibody-treated mice had higher numbers of CD68(+) cells and apoptotic cells in intestinal villi. Our results confirm that radiation exposure induces elevations of circulating G-CSF and IL-6. Neutralizing antibody to G-CSF exacerbates the deleterious effects of radiation, indicating that G-CSF induced in response to irradiation plays an important role in recovery. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487481     DOI: 10.1016/j.cyto.2012.03.011

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  26 in total

Review 1.  Nonhuman primates as models for the discovery and development of radiation countermeasures.

Authors:  Vijay K Singh; Ayodele O Olabisi
Journal:  Expert Opin Drug Discov       Date:  2017-05-05       Impact factor: 6.098

2.  IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms.

Authors:  Lukas F Mager; Carsten Riether; Christian M Schürch; Yara Banz; Marie-Hélène Wasmer; Regula Stuber; Alexandre P Theocharides; Xiaohong Li; Yu Xia; Hirohisa Saito; Susumu Nakae; Gabriela M Baerlocher; Markus G Manz; Kathy D McCoy; Andrew J Macpherson; Adrian F Ochsenbein; Bruce Beutler; Philippe Krebs
Journal:  J Clin Invest       Date:  2015-05-26       Impact factor: 14.808

3.  Soluble factors secreted by human Wharton's jelly mesenchymal stromal/stem cells exhibit therapeutic radioprotection: A mechanistic study with integrating network biology.

Authors:  Dharmendra Kumar Maurya; Mayuri Bandekar; Santosh Kumar Sandur
Journal:  World J Stem Cells       Date:  2022-05-26       Impact factor: 5.247

4.  Tocols induce G-CSF and mobilise progenitors that mitigate radiation injury.

Authors:  Vijay K Singh; Patricia L P Romaine; Victoria L Newman; Thomas M Seed
Journal:  Radiat Prot Dosimetry       Date:  2014-07-03       Impact factor: 0.972

5.  Combined Therapy of Pegylated G-CSF and Alxn4100TPO Improves Survival and Mitigates Acute Radiation Syndrome after Whole-Body Ionizing Irradiation Alone and Followed by Wound Trauma.

Authors:  Juliann G Kiang; Min Zhai; David L Bolduc; Joan T Smith; Marsha N Anderson; Connie Ho; Bin Lin; Suping Jiang
Journal:  Radiat Res       Date:  2017-08-29       Impact factor: 2.841

6.  Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.

Authors:  Dapeng Wang; Yu Yu; Kelley Haarberg; Jianing Fu; Kane Kaosaard; Srinivas Nagaraj; Claudio Anasetti; Dmitry Gabrilovich; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-30       Impact factor: 5.742

Review 7.  Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.

Authors:  Vijay K Singh; Patricia L P Romaine; Thomas M Seed
Journal:  Health Phys       Date:  2015-06       Impact factor: 1.316

Review 8.  Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures.

Authors:  Vijay K Singh; Lindsay A Beattie; Thomas M Seed
Journal:  J Radiat Res       Date:  2013-05-08       Impact factor: 2.724

Review 9.  Vitamin E Analogs as Radiation Response Modifiers.

Authors:  Pankaj K Singh; Sunil Krishnan
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-20       Impact factor: 2.629

10.  MIP-1α/CCL3-mediated maintenance of leukemia-initiating cells in the initiation process of chronic myeloid leukemia.

Authors:  Tomohisa Baba; Kazuhito Naka; Soji Morishita; Norio Komatsu; Atsushi Hirao; Naofumi Mukaida
Journal:  J Exp Med       Date:  2013-10-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.